Cargando…
Elevated NRAS expression during DCIS is a potential driver for progression to basal-like properties and local invasiveness
BACKGROUND: Ductal carcinoma in situ (DCIS) is the most common type of in situ premalignant breast cancers. What drives DCIS to invasive breast cancer is unclear. Basal-like invasive breast cancers are aggressive. We have previously shown that NRAS is highly expressed selectively in basal-like subty...
Autores principales: | Zheng, Ze-Yi, Elsarraj, Hanan, Lei, Jonathan T., Hong, Yan, Anurag, Meenakshi, Feng, Long, Kennedy, Hilda, Shen, Yichao, Lo, Flora, Zhao, Zifan, Zhang, Bing, Zhang, Xiang H.-F., Tawfik, Ossama W., Behbod, Fariba, Chang, Eric C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578182/ https://www.ncbi.nlm.nih.gov/pubmed/36258226 http://dx.doi.org/10.1186/s13058-022-01565-5 |
Ejemplares similares
-
BCL9/STAT3 regulation of transcriptional enhancer networks promote DCIS progression
por: Elsarraj, Hanan S., et al.
Publicado: (2020) -
Regulation of DCIS to invasive breast cancer progression by Singleminded-2s (SIM2s)
por: Scribner, Kelly C., et al.
Publicado: (2012) -
Mouse‐INtraDuctal (MIND): an in vivo model for studying the underlying mechanisms of DCIS malignancy
por: Hong, Yan, et al.
Publicado: (2021) -
Contrasting DCIS and invasive breast cancer by subtype suggests basal-like DCIS as distinct lesions
por: Bergholtz, Helga, et al.
Publicado: (2020) -
Evidence That STK19 Is Not an NRAS-dependent Melanoma Driver
por: Rodríguez-Martínez, Marta, et al.
Publicado: (2020)